Convexia is an AI-maximalist pharma company focused on uncovering overlooked drug assets. Their approach integrates specialized AI agents with expert human review, streamlining the drug development process. This enables faster identification and evaluation of high-potential therapeutics, transforming traditional drug sourcing methods.
Convexia offers a range of innovative services focused on drug asset discovery and evaluation, leveraging advanced AI technologies. Their main product offerings include: